In the criminal justice system of the United States, one recent highly controversial case has thrown the inherent problems of lethal injection execution into the national spotlight: the repeated failure to put convicted murderer Christa Pike to death. After two separate attempts to carry out the court-ordered capital punishment via lethal injection fell short, legal experts, death penalty critics, and public policy commentators are now re-examining the systemic flaws that led to this unprecedented incident. As the BBC’s senior correspondent Stephanie Hegarty has investigated, a cascade of unexpected issues plagued both attempts to execute Pike, leaving state officials scrambling to explain what went wrong and what comes next for the death row inmate.
Pike was originally convicted and sentenced to death for a brutal 1995 murder that shocked the nation: when she was just 18 years old, she tortured and killed 19-year-old Colleen Slemmer, her college classmate, in a premeditated attack fueled by a personal dispute. Decades of legal appeals failed to overturn her sentence, and earlier this year, Tennessee officials scheduled her execution for a fixed date, preparing to carry out the punishment via the state’s standard lethal injection protocol.
What was supposed to be a routine execution quickly unraveled, however. According to prison officials on the scene, during the first attempt to insert an intravenous line to deliver the lethal drugs, execution teams encountered severe difficulties accessing usable veins in Pike’s arms and extremities. The team spent more than an hour repositioning and trying multiple insertion sites, but was unable to establish a stable IV line capable of delivering the fatal drug combination. After exhausting all available options, the first execution attempt was called off.
In a stunning move, state correctional officials opted to make a second attempt just hours later on the same scheduled day. Once again, the execution team failed to establish a reliable IV access route, forcing a second cancellation of the procedure. The botched two attempts left Pike alive on death row, and have sparked fierce debate across the country over the ethics and reliability of lethal injection as a method of capital punishment.
Hegarty’s reporting points to longstanding concerns that have been raised by medical experts and death penalty opponents for years: many death row inmates, particularly those with a history of intravenous drug use or other medical conditions that damage veins, present significant challenges for IV insertion. When combined with widespread shortages of the specific drugs approved for lethal injection in many U.S. states, and the lack of trained medical personnel willing to participate in executions due to professional ethics rules, these challenges create a high risk of botched procedures.
The case has also reignited broader debates over the future of the death penalty in the United States. Critics argue that failed executions like this one constitute cruel and unusual punishment, a violation of the U.S. Constitution’s Eighth Amendment, and are calling for an immediate moratorium on capital punishment nationwide. Supporters of the death penalty, meanwhile, have called for a review of execution protocols to address gaps that led to the failure, rather than scrapping capital punishment entirely. For now, Pike remains on death row as Tennessee officials conduct a full review of the botched attempt, with no new execution date scheduled.